Keefe, Richard S E <br/><br/>
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.  [electronic resource] 

 -  Archives of general psychiatry  Jun 2007 
 - 633-47 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-990X 
<br/><br/><label>Standard No.: </label>10.1001/archpsyc.64.6.633  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--therapeutic use<br/>Benzodiazepines--therapeutic use<br/>Cognition Disorders--diagnosis<br/>Cohort Studies<br/>Dibenzothiazepines--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Neuropsychological Tests--statistics & numerical data<br/>Olanzapine<br/>Perphenazine--therapeutic use<br/>Piperazines--therapeutic use<br/>Quetiapine Fumarate<br/>Risperidone--therapeutic use<br/>Schizophrenia--diagnosis<br/>Schizophrenic Psychology<br/>Thiazoles--therapeutic use<br/>Treatment Outcome